Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity

Author： Adamcová Michaela   Šterba Martin   Šimunek Tomáš   Potácová Anna   Popelová Olga   Mazurová Yvona   Geršl Vladimír  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.3, 2005-05, pp. : 457-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Troponin 1 elevation predicts trastuzumab-induced cardiotoxicity

By  

Reactions Weekly, Vol. 1, Iss. 1320, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Sorbitol as a marker for drug-induced decreases of variable duration in liver blood flow in healthy volunteers

By Burggraaf J.   Schoemaker R.C.   Lentjes E.G.W.M.   Cohen A.F.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 2, 2000-12 ,pp. : 133-139

Elsevier

Access to resources Recommend Favorite

Drug-induced mitochondrial toxicity

By Chan Katie   Truong Don   Shangari Nandita   O’Brien Peter J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 4, 2005-12 ,pp. : 655-669

Informa Healthcare

Access to resources Recommend Favorite

Drug-induced myopathies

By Bannwarth Bernard  

Expert Opinion on Drug Safety, Vol. 1, Iss. 1, 2002-05 ,pp. : 65-70

Informa Healthcare

Access to resources Recommend Favorite

Treatment of drug-induced thrombocytopenia

By George James N   Medina Patrick J   Zondor Stacey D  

Expert Opinion on Drug Safety, Vol. 1, Iss. 2, 2002-07 ,pp. : 173-180

Informa Healthcare

Access to resources Recommend Favorite